Found: 49
Select item for more details and to access through your institution.
Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 3, p. 1, doi. 10.1093/ofid/ofab092
- By:
- Publication type:
- Article
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graftversus-host disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.959658
- By:
- Publication type:
- Article
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.
- Published in:
- Hematology Reports, 2017, v. 9, n. 3, p. 102, doi. 10.4081/hr.2017.7083
- By:
- Publication type:
- Article
Cytomegalovirus immunoglobulin G: passive transfer or prior infection?
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 11, doi. 10.1111/bjh.17755
- By:
- Publication type:
- Article
Pure red blood cell aplasia: patient management pitfalls in major ABO‐incompatible haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 701, doi. 10.1111/bjh.17465
- By:
- Publication type:
- Article
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
- By:
- Publication type:
- Article
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 19, p. 1711, doi. 10.2146/ajhp080325
- By:
- Publication type:
- Article
Optimizing autologous stem cell collections for patients with multiple myeloma receiving G‐CSF and Plerixafor: A single center project.
- Published in:
- Journal of Clinical Apheresis, 2024, v. 39, n. 3, p. 1, doi. 10.1002/jca.22127
- By:
- Publication type:
- Article
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 2, p. 149, doi. 10.2146/ajhp110149
- By:
- Publication type:
- Article
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Prognostic Significance of Leukopenia at the Time of Diagnosis in Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 5, p. 427, doi. 10.1016/j.clml.2011.03.035
- By:
- Publication type:
- Article
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 10, p. 2171, doi. 10.1002/cncr.21852
- By:
- Publication type:
- Article
ABCL-378: Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S396, doi. 10.1016/S2152-2650(21)01898-X
- By:
- Publication type:
- Article
Poster: ABCL-378: Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S240, doi. 10.1016/S2152-2650(21)01509-3
- By:
- Publication type:
- Article
Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and Engraftment Parameters for Bloodless Transplants among Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e68, doi. 10.1016/j.clml.2017.03.124
- By:
- Publication type:
- Article
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 8, p. 1255, doi. 10.1093/cid/ciy706
- By:
- Publication type:
- Article
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma.
- Published in:
- Transfusion, 2013, v. 53, n. 1, p. 76, doi. 10.1111/j.1537-2995.2012.03719.x
- By:
- Publication type:
- Article
Effectiveness and cost analysis of 'just-in-time' salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
- Published in:
- Transfusion, 2011, v. 51, n. 10, p. 2175, doi. 10.1111/j.1537-2995.2011.03136.x
- By:
- Publication type:
- Article
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease
- Published in:
- Transfusion, 2010, v. 50, n. 11, p. 2424, doi. 10.1111/j.1537-2995.2010.02712.x
- By:
- Publication type:
- Article
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
- Published in:
- Transfusion, 2007, v. 47, n. 4, p. 629, doi. 10.1111/j.1537-2995.2007.01164.x
- By:
- Publication type:
- Article
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: A meta-analysis of phase 3 randomized clinical trials.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Bortezomib-containing induction regimens in transplant-eligible myeloma patients.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 23, p. 4119, doi. 10.1002/cncr.28325
- By:
- Publication type:
- Article
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3784, doi. 10.1002/cncr.28253
- By:
- Publication type:
- Article
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5278, doi. 10.1002/cncr.27494
- By:
- Publication type:
- Article
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3556, doi. 10.1002/cncr.26664
- By:
- Publication type:
- Article
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 428, doi. 10.1002/cncr.26290
- By:
- Publication type:
- Article
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1245, doi. 10.1002/cncr.25678
- By:
- Publication type:
- Article
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1586, doi. 10.1634/theoncologist.2020-0442
- By:
- Publication type:
- Article
Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 1, p. n/a, doi. 10.1111/tid.12649
- By:
- Publication type:
- Article
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 17, p. 1874, doi. 10.1001/jama.2011.1558
- By:
- Publication type:
- Article
Why does the place where the allogeneic transplant patient calls home matter?
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 4, p. 510, doi. 10.1002/cncr.33231
- By:
- Publication type:
- Article
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2007, v. 44, n. 1, p. 2, doi. 10.1086/508774
- By:
- Publication type:
- Article
Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 12, p. 1726, doi. 10.1086/504328
- By:
- Publication type:
- Article
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 3, p. 758, doi. 10.1046/j.1365-2141.1996.424984.x
- By:
- Publication type:
- Article